Press releaseGlobe Newswire
Mesoblast
MESO · ASX
$12.28−$0.27 (−2.15%)TodayMarket closed ·
Prev close $12.55
Latest news
- Press releaseGlobe Newswire
Mesoblast Reports Substantial Revenue Growth to US$120M
- News
Full Transcript: Mesoblast FY 2026 Earnings Call
- NewsAvi Kapoor
Flowers Foods Posts Downbeat Q2 Results, Joins OSI Systems, Aveanna Healthcare And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
- NewsVandana Singh
Mesoblast Targets $10 Billion Market With Regenerative Back Pain Treatment
- NewsAvi Kapoor
H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Moving Higher On Monday
- Press releaseGlobe Newswire
Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain
- Press releaseGlobe Newswire
Mesoblast Reports Ryoncil® Net Revenues of US$36M for the Quarter and US$115M for First Full Year of Product Launch
- NewsAvi Kapoor
PayPal, Veradermics, Alibaba And Other Big Stocks Moving Higher On Wednesday
- Press releaseGlobe Newswire
Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
- Press releaseGlobe Newswire
Ryoncil® Delivers Net Revenue of US$36M for the Fourth Quarter Ended 30 June 2026
- News
9 Health Care Stocks Whale Activity In Today’s Session
- Press releaseGlobe Newswire
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs
- News
10 Health Care Stocks With Whale Alerts In Today’s Session
- Press releaseGlobe Newswire
Mesoblast Draws US$50 Million from Five-Year Non-Dilutive Facility
- Press releasePRNewswire
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
- Press releaseGlobe Newswire
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven't Noticed
- Press releasePRNewswire
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.
- Press releasePRNewswire
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
- News
Earnings Scheduled For February 26, 2026
- News
What's Next: Mesoblast's Earnings Preview
- NewsVandana Singh
Mesoblast Touts High Survival Rates For FDA-Approved Cell Therapy
- NewsVandana Singh
Mesoblast Says Most Children Survive After Early Use Of FDA-Approved Cell Therapy For Organ Transplant Related Complication
- NewsVandana Singh
FDA Signals Support For Mesoblast's Cell Therapy For Chronic Back Pain
- NewsAvi Kapoor
Exelixis, Citigroup And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- News
10 Health Care Stocks Whale Activity In Today's Session
- Press releasePRNewswire
Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy
- NewsAvi Kapoor
Urban Outfitters, Arrowhead Pharmaceuticals, Petco Health and Wellness And Other Big Stocks Moving Higher On Wednesday
- NewsAvi Kapoor
Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
This Brinker International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
- NewsAvi Kapoor
Bitfarms, Standard Lithium, Terawulf And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- NewsAvi Kapoor
Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- NewsAvi Kapoor
Nasdaq Down Over 1%; Alibaba Shares Jump Following Q1 Results
- NewsAvi Kapoor
Why Greenbrier Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday
- NewsAvi Kapoor
US Steel Issues Weak Q4 Outlook, Joins Novo Nordisk And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- NewsRishabh Mishra
US Stocks Likely To Open Higher After Plunging On Powell's Hawkish Comments: Analyst Calls It A 'Healthy' Reaction From An 'Overly Optimistic' Market
- NewsVandana Singh
Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges
- NewsAvi Kapoor
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Broadcom Posts Strong Results, Joins RH, Upstart And Other Big Stocks Moving Higher On Friday
- NewsAvi Kapoor
SentinelOne, AeroVironment, PVH And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
- NewsAvi Kapoor
Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday
- Press releaseBusiness Wire
KaliVir Immunotherapeutics Appoints Schond Greenway as Chief Financial Officer
- NewsAvi Kapoor
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
- NewsAvi Kapoor
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- NewsAvi Kapoor
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
- NewsAvi Kapoor
Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.